These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7617655)
1. p53 immunostaining in the differentiation of inflammatory pseudotumor from sarcoma involving the lung. Ledet SC; Brown RW; Cagle PT Mod Pathol; 1995 Apr; 8(3):282-6. PubMed ID: 7617655 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176 [TBL] [Abstract][Full Text] [Related]
3. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas. Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593 [TBL] [Abstract][Full Text] [Related]
4. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of p53 protein in uterine sarcomas. Nordal RR; Kristensen GB; Stenwig AE; Tropé CG; Nesland JM Gynecol Oncol; 1998 Jul; 70(1):45-8. PubMed ID: 9698472 [TBL] [Abstract][Full Text] [Related]
7. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Ebina M; Steinberg SM; Mulshine JL; Linnoila RI Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277 [TBL] [Abstract][Full Text] [Related]
8. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948 [TBL] [Abstract][Full Text] [Related]
9. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. Soini Y; Vähäkangas K; Nuorva K; Kamel D; Lane DP; Pääkkö P J Pathol; 1992 Sep; 168(1):29-33. PubMed ID: 1333524 [TBL] [Abstract][Full Text] [Related]
10. Significance of p53 expression in immature teratomas. Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994 [TBL] [Abstract][Full Text] [Related]
11. Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung. Cagle PT; Fraire AE; Greenberg SD; Cox A; Brown RW Hum Pathol; 1996 Nov; 27(11):1198-203. PubMed ID: 8912831 [TBL] [Abstract][Full Text] [Related]
12. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Zen Y; Kitagawa S; Minato H; Kurumaya H; Katayanagi K; Masuda S; Niwa H; Fujimura M; Nakanuma Y Hum Pathol; 2005 Jul; 36(7):710-7. PubMed ID: 16084938 [TBL] [Abstract][Full Text] [Related]
13. Value of ancillary studies in fine needle aspiration cytology of the lung. O'Reilly PE; Brueckner J; Silverman JF Acta Cytol; 1994; 38(2):144-50. PubMed ID: 8147203 [TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry. Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156 [TBL] [Abstract][Full Text] [Related]
15. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of immunohistochemically detected p53 protein expression in non-small cell lung cancer treated with radiation therapy. Hayakawa K; Mitsuhashi N; Hasegawa M; Saito Y; Sakurai H; Ohno T; Maebayashi K; Ebara T; Hayakawa KY; Niibe H Anticancer Res; 1998; 18(5B):3685-8. PubMed ID: 9854477 [TBL] [Abstract][Full Text] [Related]
17. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310 [TBL] [Abstract][Full Text] [Related]
18. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Bhargava V; Thor A; Deng G; Ljung BM; Moore DH; Waldman F; Benz C; Goodson W; Mayall B; Chew K Mod Pathol; 1994 Apr; 7(3):361-8. PubMed ID: 8058709 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of p53 protein examination in lung cancer through preoperative fibro-optic bronchoscope brushing and biospy]. Yu Q; Xiao Z; Liu G Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):445-7. PubMed ID: 10920941 [TBL] [Abstract][Full Text] [Related]
20. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]